Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03026192 · ClinicalTrials.gov registry record
Near Infrared Spectroscopy to Determine Patent Ductus Arteriosus Closure
A clinical trial, sponsored by Albany Medical College.
- Terminated
- Registry status
- 4
- Enrollment target
NCT03026192: Clinical Trial study, sponsored by Albany Medical College.
NCT03026192 is a clinical trial that was terminated before completion, run by Albany Medical College. The registered enrollment target is 4 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03026192 was terminated before completion, sponsored by Albany Medical College.
- TERMINATED
- Registry status
- 4 participants
- Enrollment target
Study Summary
Using cerebral and renal near infrared spectroscopy monitoring to determine PDA closure in preterm infants after completing medical treatment for a hemodynamically significant PDA.
Interventions
- DEVICE near infrared spectroscopy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2016-12 |
| Est. Completion | 2018-06-30 |
Why NCT03026192 stopped before completion
NCT03026192 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 4 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which near infrared spectroscopy is the first listed.
NCT03026192 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03026192 about?
NCT03026192 is a clinical study titled "Near Infrared Spectroscopy to Determine Patent Ductus Arteriosus Closure". Using cerebral and renal near infrared spectroscopy monitoring to determine PDA closure in preterm infants after completing medical treatment for a hemodynamically significant PDA.
What is the current status of trial NCT03026192?
This trial is currently terminated. The enrollment target is 4 participants. The study started on 2016-12. Estimated completion is 2018-06-30.
What interventions are being tested in trial NCT03026192?
The interventions under investigation include: near infrared spectroscopy (DEVICE).
Who is sponsoring clinical trial NCT03026192?
This trial is sponsored by Albany Medical College, which has 52 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia